FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
BioLineRx Receives Approval to Commence Phase 1 Trial for Novel Stem Cell Mobilization Treatment
June 16, 2014
Aegis Capital Keeps BioLineRx (BLRX) at 'Buy' Following Q2 Results; Plenty of Catalysts Ahead
August 06, 2014
BioLineRx Receives Notice of Allowance for US Patent Covering Novel Treatment for Celiac Disease
June 11, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here